Detalles de la búsqueda
1.
A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-441655
2.
Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-436684
3.
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-428137
4.
A pH-dependent switch mediates conformational masking of SARS-CoV-2 spike
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-187989
5.
Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-477770
6.
Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-474491
7.
Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-474307
8.
Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-444010
9.
Booster of mRNA-1273 Vaccine Reduces SARS-CoV-2 Omicron Escape from Neutralizing Antibodies
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21267805
10.
Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-437942
11.
A multispecific antibody confers pan-reactive SARS-CoV-2 neutralization and prevents immune escape
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-502029
12.
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-166033
13.
Broadly neutralizing antibodies target the coronavirus fusion peptide
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-487879
14.
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-432969
15.
LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-318972
16.
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-145920
17.
Convergent epitope specificities, V gene usage and public clones elicited by primary exposure to SARS-CoV-2 variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-486152
18.
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-465542
19.
Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman Primates
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-456015
20.
LY-CoV1404 potently neutralizes SARS-CoV-2 variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-442182